Tevano Systems Holdings Inc.

TEVO.CN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, TEVO.CN stands at 1.39M. In comparison, BLCO.TO has a market cap of 5.99B. Regarding current trading prices, TEVO.CN is priced at $0.02, while BLCO.TO trades at $16.94.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

TEVO.CN currently has a P/E ratio of -0.67, whereas BLCO.TO's P/E ratio is -11.85. In terms of profitability, TEVO.CN's ROE is +3.22%, compared to BLCO.TO's ROE of -0.06%. Regarding short-term risk, TEVO.CN is less volatile compared to BLCO.TO. This indicates potentially lower risk in terms of short-term price fluctuations for TEVO.CN.

TEVO.CN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, TEVO.CN stands at 1.39M. In comparison, HTL.TO has a market cap of 345.34M. Regarding current trading prices, TEVO.CN is priced at $0.02, while HTL.TO trades at $2.24.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

TEVO.CN currently has a P/E ratio of -0.67, whereas HTL.TO's P/E ratio is -112.00. In terms of profitability, TEVO.CN's ROE is +3.22%, compared to HTL.TO's ROE of -0.03%. Regarding short-term risk, TEVO.CN and HTL.TO have similar daily volatility (0.00).

TEVO.CN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, TEVO.CN stands at 1.39M. In comparison, OPS.TO has a market cap of 334.89M. Regarding current trading prices, TEVO.CN is priced at $0.02, while OPS.TO trades at $2.90.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

TEVO.CN currently has a P/E ratio of -0.67, whereas OPS.TO's P/E ratio is -26.32. In terms of profitability, TEVO.CN's ROE is +3.22%, compared to OPS.TO's ROE of -0.17%. Regarding short-term risk, TEVO.CN is less volatile compared to OPS.TO. This indicates potentially lower risk in terms of short-term price fluctuations for TEVO.CN.

TEVO.CN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, TEVO.CN stands at 1.39M. In comparison, BLMH.CN has a market cap of 3.81M. Regarding current trading prices, TEVO.CN is priced at $0.02, while BLMH.CN trades at $0.08.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

TEVO.CN currently has a P/E ratio of -0.67, whereas BLMH.CN's P/E ratio is 0.89. In terms of profitability, TEVO.CN's ROE is +3.22%, compared to BLMH.CN's ROE of -0.17%. Regarding short-term risk, TEVO.CN and BLMH.CN have similar daily volatility (0.00).